Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jo Collier
BCX7353, a Potent Inhibitor of Plasma Kallikrein, Shows Sustained Maximal Enzyme Inhibition When Dosed Orally Once Daily: Results From a Phase I Trial in Healthy Subjects
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Sustained-Release Ruxolitinib: Findings From a Phase 1 Study in Healthy Subjects and a Phase 2 Study in Patients With Myelofibrosis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pharmacodynamic and Pharmacokinetic Profile of S 17092, a New Orally Active Prolyl Endopeptidase Inhibitor, in Elderly Healthy Volunteers. A Phase I Study
British Journal of Clinical Pharmacology
Pharmacology
Single-Dose Pharmacokinetics of Co-Crystal of Tramadol-Celecoxib: Results of a 4-Way Randomized Open-Label Phase I Clinical Trial in Healthy Subjects
British Journal of Clinical Pharmacology
Pharmacology
Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
Clinical Drug Investigation
Medicine
Pharmacology
Effect of Diet on Serum Creatinine in Healthy Subjects During a Phase I Study
Journal of Clinical Medicine Research
The EZH2 Inhibitor Tazemetostat Is Well Tolerated in a Phase I Trial
Cancer Discovery
Oncology
TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Gene Therapy for Pain: Results of a Phase I Clinical Trial
Annals of Neurology
Neurology
